Positron Corp. (OTCMKTS:POSC) Shares Shorted: Short Interest Up 387.8% in October

Positron Corp. (OTCMKTS:POSC) was the target of a large growth in short interest in October. As of October 30th, there was short interest totaling 1,278 shares, a growth of 387.8% from the October 15th total of 262 shares. Approximately 0.0% of the company’s stock are short sold. Based on an average trading volume of 11,347 shares, the days-to-cover ratio is presently 0.1 days.

Positron Price Performance

POSC stock traded up $0.03 during trading hours on Wednesday, reaching $1.75. 3,629 shares of the stock were exchanged, compared to its average volume of 41,289. The firm’s 50-day moving average is $1.73 and its 200-day moving average is $1.82. The company has a market cap of $57.92 million, a price-to-earnings ratio of -5.47 and a beta of 0.67. Positron has a 12 month low of $1.27 and a 12 month high of $2.74.

Positron (OTCMKTS:POSC) last released its quarterly earnings results on Friday, August 14th. The company reported ($0.03) earnings per share (EPS) for the quarter. The firm had revenue of $0.11 million during the quarter. Positron had a negative net margin of 2,279.55% and a negative return on equity of 2,415.88%.

About Positron

Positron Corporation (OTCMKTS: POSC) is a medical technology company focused on positron emission tomography (PET), a nuclear-imaging technique used to support the diagnosis and management of disease. Its activities include the development, manufacture and distribution of PET imaging systems and related products for healthcare providers. The company has emphasized cardiac PET imaging, an application that can help physicians evaluate heart function and blood flow. Positron’s product offerings have included dedicated PET equipment, such as the Attrius PET system, along with related imaging and radiopharmaceutical solutions.